SPRUCE BIOSCIENCES INC
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
SPRB$46.55+9.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
(in thousands, except share and per share amounts)
| September 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $60,055 | $96,339 |
| Prepaid expenses | 2,658 | 3,876 |
| Other current assets | 860 | 1,968 |
| Total current assets | 63,573 | 102,183 |
| Right-of-use assets | 998 | 1,181 |
| Other assets | 531 | 582 |
| Total assets | $65,102 | $103,946 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,799 | $3,332 |
| Accrued expenses and other current liabilities | 7,740 | 14,600 |
| Term loan, current portion | 1,622 | 1,622 |
| Deferred revenue, current portion | 697 | 4,911 |
| Total current liabilities | 11,858 | 24,465 |
| Lease liabilities, net of current portion | 809 | 1,019 |
| Term loan, net of current portion | 524 | 1,717 |
| Other liabilities | 273 | 236 |
| Total liabilities | 13,464 | 27,437 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of September 30, 2024 and December 31, 2023 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 41,302,599 and 41,029,832 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 4 | 4 |
| Additional paid-in capital | 278,343 | 273,737 |
| Accumulated deficit | (226,709) | (197,232) |
| Total stockholders’ equity | 51,638 | 76,509 |
| Total liabilities and stockholders’ equity | $65,102 | $103,946 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.